Featured image of the article Byome Labs raises €3.6 million to pioneer instant in-store skin microbiome testing.

Unveiling the Intellectual Property Behind Byome’s Skin Microbiota Diagnostic Technology

SOPHIA ANTIPOLIS, France – October 08, 2025 │ French startup Byome Labs has successfully closed a seed funding round to accelerate the industrialization of Byome Derma, its fast and simple skin microbiome testing solution. KnowMade decodes the science behind the news. About Byome Labs Founded in 2023, Byome Labs is an innovative deeptech startup headquartered[…]

Featured image of the article Launch of a new Skin Activator Hydrating & Firming skincare segment: focus on Galderma’s IP strategy.

Launch of a new Skin Activator Hydrating & Firming skincare segment: focus on Galderma’s IP strategy

SOPHIA ANTIPOLIS, France – October 03, 2025 │ With the launch of Cetaphil’s new Skin Activator Hydrating & Firming Line, Galderma makes a step ahead to address skins affected by dermatoporosis. KnowMade deciphers this new formula. Galderma at a glance Originally founded in 1981 as a joint venture between Nestlé and L’Oréal, Galderma became an[…]

Featured image of the article CILA Therapeutics: A Newcomer Shaping Pulmonary Drug and mRNA Delivery.

CILA Therapeutics: A Newcomer Shaping Pulmonary Drug and mRNA Delivery

SOPHIA ANTIPOLIS, France – July 16, 2025 │ KnowMade actively tracks therapeutic mRNA innovations as part of its Therapeutic mRNA patent monitoring service. What’s new today? Spotlight on Emerging Innovators: The Strategic Value of Patent Monitoring The first half of 2025 confirms the ongoing momentum in therapeutic mRNA innovation, as highlighted in KnowMade’s press release[…]

Featured image of the article Amplitude Therapeutics a promising newcomer in therapeutic mRNA field.

Amplitude Therapeutics a promising newcomer in therapeutic mRNA field

SOPHIA ANTIPOLIS, France – July 11, 2025 │ KnowMade actively tracks therapeutic mRNA innovations as part of its Therapeutic mRNA patent monitoring service. What’s new today? Emerging Innovators in a Record-Setting Quarter for Therapeutic mRNA The continued innovation in therapeutic mRNA is confirmed through the first half of 2025, as reflected by KnowMade’s Therapeutic mRNA[…]